The Valley Desk

Clinical trial reportJournal of the European Academy of Dermatology and Venereology : JEADVPublished

Durability of response to icotrokinra for high-impact site psoriasis: 1-year ICONIC-TOTAL findings

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of the European Academy of Dermatology and Venereology : JEADV
Published
Subject terms
Humans; Psoriasis; Peptides, Cyclic; Treatment Outcome; Severity of Illness Index; Double-Blind Method; Adult; Aged; Middle Aged; Female; Male; Young Adult
PubMed ID
42175814
PubMed Central ID
PMC13505761
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal